🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Singapore / NCT07177612
Enrolling by invitation Observational

Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).

NCT07177612 · tracked via the Priya Life Science Singapore tracker
Phase
Observational
Started
2025-09-09
Last updated
2025-09-22

Condition(s) studied

Lipoprotein(a)Lipoprotein(a), Hyper-Lp(a)-Emia

Study summary

The goal of this observational study is to assess the if short educational videos about #LILAC-for-Lpa are feasible and accepted in improving the confidence, testing, and management on Lipoprotein(a).

Eligibility

Sex
ALL
Min age
16 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Participants include students, participants from institute of higher learning aged 16 and above. * Participants aged 16 and above regardless of local or overseas, may also be from educational talks that Dr Loh is invited to speak at. * Patients and members of the public aged 16 and above if they attend lipid awareness educational events. * Participants aged 16 and above in patient support groups or patient advocacy networks. Exclusion Criteria: * Participants aged below 16 years old.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Online Portal, Australia Perth Australia
Online web portal Kuala Lumpur Malaysia
Changi General Hospital Singapore Singapore

More Changi General Hospital trials in Singapore

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07177612 on ClinicalTrials.gov ↗ ← All trials in Singapore